When can Semaglutide be discontinued after achieving its therapeutic goal?

When can Semaglutide be discontinued after achieving its therapeutic goal? Can polycystic ovary patients use it? What are the common misconceptions during the medication process? These key issues directly affect the safety and ultimate effectiveness of treatment, and are the core demands that many users have not been satisfied with.
Stopping medication should follow the principle of “achieving standard stability control+gradually reducing dosage” and should not be blindly stopped. If the glycated hemoglobin is stable at 6.5% -7.0%, fasting blood glucose is normal, and there are no obvious complications, the dosage can be gradually reduced under the guidance of a doctor (such as from 1.0mg/week to 0.5mg/week), and the medication should be evaluated for 8-12 weeks before stopping; If the weight loss population reaches their ideal weight (BMI<24) and their dietary and exercise habits have been developed, they can first reduce the dosage by half for 4 weeks, and then decide whether to stop taking the medication based on weight changes. Sudden discontinuation of medication may lead to a rebound in blood sugar and rapid weight gain, requiring extra caution.
Polycystic ovary syndrome (PCOS) patients are potential beneficiaries of Semaglutide. Clinical studies have shown that it can help PCOS patients regulate their menstrual cycle and lose weight (average weight loss of 8-10kg) by improving insulin resistance and reducing high androgen levels, without affecting fertility. It is suitable for PCOS obese patients without contraceptive needs. However, it should be noted that medication for PCOS patients should start from the lowest dose while monitoring hormone levels and ovarian function.
Misunderstandings in medication should be avoided with emphasis. Some users believe that ‘medication can eliminate the need for dietary control’, but in reality, medication is only an aid, and a high sugar and high-fat diet can weaken the therapeutic effect and worsen gastrointestinal reactions; Some people increase the dosage without authorization in pursuit of quick results, which may actually increase the risk of adverse reactions; In addition, blindly using Semaglutide as a “beauty and weight loss drug” for healthy individuals may cause endocrine disorders, and the principle of “prescription drugs are only used for the indicated population” should be strictly followed.
Whether you are a standard patient seeking to discontinue medication, a PCOS patient, or a newcomer to Semaglutide, it is important to clarify the discontinuation criteria and avoid medication misconceptions in order to make treatment safer and more efficient. If you need a detailed medication plan for special indications such as PCOS, or want to know if you meet the conditions for discontinuation, it is recommended to consult a specialist doctor for professional guidance in a timely manner.